Summit Therapeutics (SMMT) said Wednesday it has named Ankur Dhingra its chief financial officer. Dhingra, who previously served as the CFO of CAREDx...
CareDx (CDNA) said Monday Chief Financial Officer Ankur Dhingra has resigned to pursue another career opportunity and Abhishek Jain has been named interim...
...
...
| Address | 1 Tower Place South San Francisco, California 94080 |
| Phone | +1.415.287.2300 |
| Number of Employees | 231 |
| Recent SEC Filing | 06/21/2022 4 |
| President, Chief Executive Officer & Director | Reginald Seeto |
| CFO, Chief Accounting Officer, VP & Controller | Abhishek Jain |
| Senior Vice President-Technology | Amitabh Shukla |
| Senior VP-Medical Affairs & Clinical Operations | Sham Dholakia |
| Price Open | $23.81 |
| Previous Close | $21.92 |
| 52 Week Range | $19.35 - 96.88 |
| Market Capitalization | $1.2 B |
| Shares Outstanding | 53.2 M |
| Sector | Health Technology |
| Industry | Medical Specialties | Next Earnings Announcement | 08/04/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.91 |
| Beta vs. S&P 500 | N/A |
| Revenue | $76.6 M |
| Net Profit Margin | -16.09% |
| Return on Equity | -10.58% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
